795 results on '"Denkinger, Claudia M"'
Search Results
2. Evaluation of the Xpert MTB Host Response assay for the triage of patients with presumed pulmonary tuberculosis: a prospective diagnostic accuracy study in Viet Nam, India, the Philippines, Uganda, and South Africa
3. Blazing the trail for innovative tuberculosis diagnostics
4. Cost-effectiveness of Low-complexity Screening Tests in Community-based Case-finding for Tuberculosis
5. Circulating cell-free RNA in blood as a host response biomarker for detection of tuberculosis
6. Clinical accuracy of instrument-based SARS-CoV-2 antigen diagnostic tests: a systematic review and meta-analysis
7. Knowledge and trust of mothers regarding childhood vaccination in Rwanda
8. From voice to ink (Vink): development and assessment of an automated, free-of-charge transcription tool
9. Innovative COVID-19 point-of-care diagnostics suitable for tuberculosis diagnosis: a scoping review protocol
10. Target product profiles: tests for tuberculosis treatment monitoring and optimization/ Profils de produits cibles: essais pour le suivi et l'optimisation du traitement de la tuberculose/ Perfiles de productos objetivo: pruebas para el seguimiento y la optimizacion del tratamiento de la tuberculosis
11. Cost and cost-effectiveness of four different SARS-CoV-2 active surveillance strategies: evidence from a randomised control trial in Germany
12. Placing the values and preferences of people most affected by TB at the center of screening and testing: an approach for reaching the unreached
13. Computer-aided detection of tuberculosis from chest radiographs in a tuberculosis prevalence survey in South Africa: external validation and modelled impacts of commercially available artificial intelligence software
14. Diagnostic yield as an important metric for the evaluation of novel tuberculosis tests: rationale and guidance for future research
15. Comparing SARS-CoV-2 antigen-detection rapid diagnostic tests for COVID-19 self-testing/self-sampling with molecular and professional-use tests: a systematic review and meta-analysis
16. Updating the approaches to define susceptibility and resistance to anti-tuberculosis agents: implications for diagnosis and treatment
17. The Potential Impact of Urine-LAM Diagnostics on Tuberculosis Incidence and Mortality: A Modelling Analysis
18. Diagnostic Accuracy of a Novel Tuberculosis Point-of-Care Urine Lipoarabinomannan Assay for People Living with HIV: A Meta-Analysis of Individual In- and Outpatient Data
19. Prevalence of infectious diseases, immunity to vaccine-preventable diseases and chronic medical conditions among Ukrainian refugees in Germany – A cross sectional study from the German Network University Medicine (NUM)
20. Tuberculosis treatment monitoring tests during routine practice: study design guidance
21. Evaluation of the Xpert MTB Host Response assay for the triage of patients with presumed pulmonary tuberculosis: a prospective diagnostic accuracy study in Viet Nam, India, the Philippines, Uganda, and South Africa
22. Validating novel diagnostic assays for tuberculosis in the context of existing tools.
23. Accuracy of package inserts of SARS-CoV-2 rapid antigen tests: a secondary analysis of manufacturer versus systematic review data
24. “I got tested at home, the help came to me”: acceptability and feasibility of home‐based TB testing of household contacts using portable molecular diagnostics in South Africa
25. Scientific advances and the end of tuberculosis: a report from the Lancet Commission on Tuberculosis
26. Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19: a randomized clinical trial
27. Diagnostic yield of urine lipoarabinomannan and sputum tuberculosis tests in people living with HIV: a systematic review and meta-analysis of individual participant data
28. Diagnostic sensitivity of SILVAMP TB-LAM (FujiLAM) point-of-care urine assay for extra-pulmonary tuberculosis in people living with HIV
29. Global prevalence of hepatitis B or hepatitis C infection among patients with tuberculosis disease: systematic review and meta-analysis
30. Rapid comparative evaluation of SARS-CoV-2 rapid point-of-care antigen tests
31. Host blood protein biomarkers to screen for Tuberculosis disease: a systematic review and meta-analysis
32. Treatment of chronic COVID‐19 with convalescent/postvaccination plasma in patients with hematologic malignancies
33. Highly valued despite burdens: Qualitative implementation research on rapid tests for hospital-based SARS-CoV-2 screening
34. Guidance for Studies Evaluating the Accuracy of Tuberculosis Triage Tests
35. Whole-genome and targeted sequencing of drug-resistant Mycobacterium tuberculosis on the iSeq100 and MiSeq: A performance, ease-of-use, and cost evaluation
36. Sensitive electrochemiluminescence (ECL) immunoassays for detecting lipoarabinomannan (LAM) and ESAT-6 in urine and serum from tuberculosis patients
37. A novel sensitive immunoassay targeting the MTX-Lipoarabinomannan epitope meets the WHO's performance target for Tuberculosis diagnosis
38. A Novel Sensitive Immunoassay Targeting the 5-Methylthio-d-Xylofuranose-Lipoarabinomannan Epitope Meets the WHO's Performance Target for Tuberculosis Diagnosis.
39. Investigating resistance in clinical Mycobacterium tuberculosis complex isolates with genomic and phenotypic antimicrobial susceptibility testing: a multicentre observational study
40. Strengthening resistance testing for tuberculosis in India - Investment cost, throughput, and efficiency of new laboratories
41. Diagnostic accuracy of WHO screening criteria to guide lateral-flow lipoarabinomannan testing among HIV-positive inpatients: A systematic review and individual participant data meta-analysis
42. Evaluation of accuracy, exclusivity, limit-of-detection and ease-of-use of LumiraDx™: An antigen-detecting point-of-care device for SARS-CoV-2
43. Bayesian latent class analysis produced diagnostic accuracy estimates that were more interpretable than composite reference standards for extrapulmonary tuberculosis tests
44. The economic cost of implementing antigen-based rapid diagnostic tests for COVID-19 screening in high-risk transmission settings: evidence from Germany
45. Detection of isoniazid, fluoroquinolone, ethionamide, amikacin, kanamycin, and capreomycin resistance by the Xpert MTB/XDR assay: a cross-sectional multicentre diagnostic accuracy study
46. The diagnostic performance of novel skin-based in-vivo tests for tuberculosis infection compared with purified protein derivative tuberculin skin tests and blood-based in vitro interferon-γ release assays: a systematic review and meta-analysis
47. A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis
48. C-reactive protein-based tuberculosis triage testing: a multi-country diagnostic accuracy study
49. Involving patients in drug development for Neglected Tropical Diseases (NTDs): A qualitative study exploring and incorporating preferences of patients with cutaneous leishmaniasis into Target Product Profile development
50. Correction: Comparison of Four Active SARS-CoV-2 Surveillance Strategies in Representative Population Sample Points: Two-Factor Factorial Randomized Controlled Trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.